Stay updated on XM02 vs. Filgrastim + Plerixafor in Stem Cell Mobilization Clinical Trial
Sign up to get notified when there's something new on the XM02 vs. Filgrastim + Plerixafor in Stem Cell Mobilization Clinical Trial page.

Latest updates to the XM02 vs. Filgrastim + Plerixafor in Stem Cell Mobilization Clinical Trial page
- Check5 days agoNo Change Detected
- Check12 days agoNo Change Detected
- Check20 days agoChange DetectedPublications section text now states that publications are automatically filled from PubMed, and the Revision tag has been updated from v3.2.0 to v3.3.2.SummaryDifference0.1%

- Check28 days agoChange DetectedThe funding notice banner about government funding has been removed from the page. This does not alter the study details or related information presented.SummaryDifference0.4%

- Check42 days agoChange DetectedAdded institutional affiliations to the page: Alvin J. Siteman Cancer Center at Barnes-Jewish Hospital and Washington University School of Medicine, and Washington University School of Medicine. A Helpful Links Provided by section was also added to the page.SummaryDifference0.6%

- Check49 days agoChange DetectedRemoved sponsor/institution attributions for 'Alvin J. Siteman Cancer Center at Barnes-Jewish Hospital and Washington University School of Medicine' and 'Washington University School of Medicine', and the 'Helpful Links Provided by' section from the page.SummaryDifference0.2%

- Check71 days agoChange DetectedThe page is updated to reflect a new version (v3.2.0) and to add a prominent notice about government funding lapse and current operating status of NIH Clinical Center; the previous version reference (v3.1.0) was removed.SummaryDifference4%

- Check78 days agoChange DetectedTerm change from Plasma cell myeloma to Multiple myeloma and an upgrade of revision from v3.0.2 to v3.1.0.SummaryDifference0.2%

Stay in the know with updates to XM02 vs. Filgrastim + Plerixafor in Stem Cell Mobilization Clinical Trial
Enter your email address, and we'll notify you when there's something new on the XM02 vs. Filgrastim + Plerixafor in Stem Cell Mobilization Clinical Trial page.